|
Press Releases |
|
|
|
Wednesday, July 19, 2017 |
|
联康生物科技获香江大健康基金注资1.2亿港元 成为集团策略性股东 |
联康生物科技集团有限公司(「联康生物科技」、「联康」或「集团」;股份代号:690)今天宣布,集团获国内知名大型综合企业香江集团牵头的香江大健康基金注资1.2亿港元成为集团策略性股东 more info >> |
|
聯康生物科技獲香江大健康基金注資1.2億港元 成為集團策略性股東 |
聯康生物科技集團有限公司(「聯康生物科技」、「聯康」或「集團」;股份代號:690)今天宣佈,集團獲國內知名大型綜合企業香江集團牽頭的香江大健康基金注資1.2億港元成為集團策略性股東 more info >> |
|
HeungKong Great Health Fund I Injects HK$120 Million into Uni-Bio Science and Becomes its Strategic Shareholder |
Uni-Bio Science Group Limited ("Uni-Bio Science", "Uni-Bio" or the "Group"; HKEx code: 690) today announced that HeungKong Great Health Fund I, led by the famed Mainland China-based corporation HeungKong Group, has invested HK$120 million in the Group and become its strategic shareholder. more info >> |
|
Monday, February 27, 2017 |
|
联康生物科技旗下药物获列入国家医保药品目录 |
联康生物科技集团有限公司(「联康生物科技」或「集团」;股份代号:690)今天宣布,其产品米格列奈今天获列入由中国人力资源和社会保障部发布的国家医保药品目录。 more info >> |
|
聯康生物科技旗下藥物獲列入國家醫保藥品目錄 |
聯康生物科技集團有限公司(「聯康生物科技」或「集團」;股份代號:690)今天宣佈,其產品米格列奈今天獲列入由中國人力資源和社會保障部發佈的國家醫保藥品目錄。 more info >> |
|
Uni-Bio Science's Drugs Officially Reimbursed under the National Reimbursement Drug List |
Uni-Bio Science Group Limited ("Uni-Bio Science" or the "Group;" HKEx code: 690) has announced that its product Mitiglinide is now to be officially reimbursed under the National Reimbursement Drug List ("NRDL") published by Ministry of Human Resources and Social Security today. more info >> |
|
Friday, August 26, 2016 |
|
联康生物科技集团公布二零一六年中期业绩 |
联康生物科技集团有限公司(「联康生物科技」或「集团」;股份代号:690)宣布截至二零一六年六月三十日止六个月之中期业绩。集团新设立的市场准入部门有效管理招标,加上成功加强其商业平台以及成功进入新的增长省份,带动集团录得强劲的财务及营运业绩。
more info >> |
|
聯康生物科技集團公佈二零一六年中期業績 |
聯康生物科技集團有限公司(「聯康生物科技」或「集團」;股份代號:690)宣佈截至二零一六年六月三十日止六個月之中期業績。集團新設立的市場准入部門有效管理招標,加上成功加強其商業平台以及成功進入新的增長省份,帶動集團錄得強勁的財務及營運業績。 more info >> |
|
Uni-Bio Science Group Announces 2016 Interim Results |
Uni-Bio Science Group Limited ("Uni-Bio Science" or the "Group"; HKEx code: 690) has announced its interim results for the six months ended 30 June 2016. more info >> |
|
Monday, June 27, 2016 |
|
联康生物科技与华润紫竹就金因舒®达成战略联盟 |
联康生物科技集团有限公司(「联康生物科技」或「集团」;股份代号:690)今天宣布,集团与华润医药集团旗下专注于在国内开发、制造及销售眼科及生殖健康用药的全资附属公司─华润紫竹药业有限公司(「华润紫竹」)签订战略联盟协议。 more info >> |
|
|
|
|
|
|
|
|
Latest Press Releases |
|
中信国际电讯CPC成为博通 (Broadcom) 战略合作伙伴 荣登VMware 云服务供应商 (VCSP) - Pinnacle更高合作级别位置
Apr 25, 2024 13:22 HKT/SGT
|
|
|
中信國際電訊CPC成為博通 (Broadcom) 戰略合作夥伴 榮登VMware 雲服務供應商 (VCSP) - Pinnacle最高合作級別位置
Apr 25, 2024 13:17 HKT/SGT
|
|
|
CITIC Telecom CPC Becomes New VMware Cloud Service Provider Pinnacle Tier Partner in the Broadcom Advantage Partner Program
Apr 25, 2024 13:07 HKT/SGT
|
|
|
《"株のアルゴリズム取引"を個人投資家も実現可能に!》 株の自動売買アプリ「Trade Stand(トレスタ)」が 大幅アップデートを発表
Apr 25, 2024 12:00: JST
|
|
|
Honda Reaches Basic Agreement with Asahi Kasei on Collaboration for Production of Battery Separators for Automotive Batteries in Canada
Apr 25, 2024 11:10 JST
|
|
|
Elevate Your Sleep Game This World Health Day with LAC
Apr 25, 2024 09:00 HKT/SGT
|
|
|
UNIQLO Sponsors KAWS + Warhol Exhibition Tour, Starting in Pittsburgh
Apr 25, 2024 9:00 JST
|
|
|
GA-ASI Selected to Build CCA for AFLCMC
Apr 25, 2024 07:00 HKT/SGT
|
|
|
FinTech Funding Continues to Surge as Second Edition of Dubai FinTech Summit Commences
Apr 25, 2024 01:47 HKT/SGT
|
|
|
The South China Sea: A Nuanced Understanding Required
Apr 24, 2024 21:12 HKT/SGT
|
|
|
Kontent.ai Introduces Mission Control and New Brand Identity, Leading a New Era of Content Management
Apr 24, 2024 20:51 HKT/SGT
|
|
|
业聚医疗合资企业在中国内地启动TricValve临床试验
Apr 24, 2024 19:07 HKT/SGT
|
|
|
業聚醫療合資企業在中國內地啟動TricValve臨床試驗
Apr 24, 2024 19:04 HKT/SGT
|
|
|
OrbusNeich's Joint Venture Kicks Off TricValve Clinical Trial in Mainland China
Apr 24, 2024 18:59 HKT/SGT
|
|
|
Legacy Credit Emerges as a Substantial Shareholder in VCI Global
Apr 24, 2024 18:00 HKT/SGT
|
|
|
|
More News >> |
|
|
|
|
|